Abstract

BackgroundAssessment of disability-adjusted life years (DALYs) resulting from non-communicable diseases (NCDs) requires specific calculation methods and input data. The aims of this study were to (i) identify existing NCD burden of disease (BoD) activities in Europe; (ii) collate information on data sources for mortality and morbidity; and (iii) provide an overview of NCD-specific methods for calculating NCD DALYs.MethodsNCD BoD studies were systematically searched in international electronic literature databases and in grey literature. We included all BoD studies that used the DALY metric to quantify the health impact of one or more NCDs in countries belonging to the European Region.ResultsA total of 163 BoD studies were retained: 96 (59%) were single-country or sub-national studies and 67 (41%) considered more than one country. Of the single-country studies, 29 (30%) consisted of secondary analyses using existing Global Burden of Disease (GBD) results. Mortality data were mainly derived (49%) from vital statistics. Morbidity data were frequently (40%) drawn from routine administrative and survey datasets, including disease registries and hospital discharge databases. The majority (60%) of national BoD studies reported mortality corrections. Multimorbidity adjustments were performed in 18% of national BoD studies.ConclusionThe number of national NCD BoD assessments across Europe increased over time, driven by an increase in BoD studies that consisted of secondary data analysis of GBD study findings. Ambiguity in reporting the use of NCD-specific BoD methods underlines the need for reporting guidelines of BoD studies to enhance the transparency of NCD BoD estimates across Europe.

Highlights

  • In the early 1990s, the World Bank published the first Global Burden of Disease and Injury (GBD) study, introducing the Disability-Adjusted Life Years (DALYs) as a key metric for assessing the burden of disease (BoD) in populations.[1,2,3] One important feature of the disability-adjusted life years (DALYs) metric is that it aggregates populations’ health losses into a single figure summarizing mortality, measured by Years of Life Lost (YLLs), and morbidity, measured by Years Lived with Disability (YLDs).[3,4] The DALY is the key element of the BoD approach: a framework for integrating all available information on fatal and non-fatal health outcomes to provide an overview of the causes of health loss

  • We collate the information on data sources for mortality and morbidity; and in a third step, we provide an overview of the non-communicable diseases (NCDs)-specific methodological choices for calculating BoD

  • This systematic review provides a comprehensive overview of the number and types of NCD BoD activities performed in Europe until early-2020

Read more

Summary

Introduction

In the early 1990s, the World Bank published the first Global Burden of Disease and Injury (GBD) study, introducing the Disability-Adjusted Life Years (DALYs) as a key metric for assessing the burden of disease (BoD) in populations.[1,2,3] One important feature of the DALY metric is that it aggregates populations’ health losses into a single figure summarizing mortality, measured by Years of Life Lost (YLLs), and morbidity, measured by Years Lived with Disability (YLDs).[3,4] The DALY is the key element of the BoD approach: a framework for integrating all available information on fatal and non-fatal health outcomes to provide an overview of the causes of health loss. Assessment of disability-adjusted life years (DALYs) resulting from non-communicable diseases (NCDs) requires specific calculation methods and input data. The aims of this study were to (i) identify existing NCD burden of disease (BoD) activities in Europe; (ii) collate information on data sources for mortality and morbidity; and (iii) provide an overview of NCD-specific methods for calculating NCD DALYs. Methods: NCD BoD studies were systematically searched in international electronic literature databases and in grey literature. Of the single-country studies, 29 (30%) consisted of secondary analyses using existing Global Burden of Disease (GBD) results. Conclusion: The number of national NCD BoD assessments across Europe increased over time, driven by an increase in BoD studies that consisted of secondary data analysis of GBD study findings.

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call